| Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses AC Tremain, RP Wallace, KM Lorentz, TB Thornley, JT Antane, MR Raczy, ... Nature Biomedical Engineering 7 (9), 1142-1155, 2023 | 17 | 2023 |
| Lymph node-targeted synthetically glycosylated antigen leads to antigen-specific immunological tolerance CD Maulloo, S Cao, EA Watkins, MM Raczy, AS Solanki, M Nguyen, ... Frontiers in Immunology 12, 714842, 2021 | 10 | 2021 |
| Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy S Cao, CD Maulloo, MM Raczy, M Sabados, AJ Slezak, M Nguyen, ... Cell Reports Medicine 5 (1), 2024 | 2 | 2024 |
| Glycopolymer-conjugated antigens as an inverse vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy S Cao, CD Maulloo, MM Raczy, M Sabados, AJ Slezak, M Nguyen, ... | 2 | 2023 |
| Synthetically glycosylated antigens as an inverse vaccine platform to prevent and treat food allergies S Cao, CD Maulloo, M Sabados, MM Raczy, DS Wilson, CR Nagler, ... The Journal of Immunology 208 (1_Supplement), 49.04-49.04, 2022 | | 2022 |
| Engineering Lymph Node-Targeting Inverse Vaccines for the Prevention and Treatment of Autoimmunity and Food Allergies CD Maulloo The University of Chicago, 2021 | | 2021 |
| Targeting antigen to lymph node lymphatic endothelial cells under steady-state to promote archiving and memory CD Maulloo, DS Wilson, JA Hubbell, MA Swartz The Journal of Immunology 202 (1_Supplement), 196.20-196.20, 2019 | | 2019 |
D. Scott WilsonJohns Hopkins Medical InstituteVerified email at jhmi.edu
